Literature DB >> 16476461

Rescue of the prototypic Arenavirus LCMV entirely from plasmid.

Ana B Sánchez1, Juan C de la Torre.   

Abstract

We document a helper-independent reverse genetics system for rescuing infectious arenaviruses from cloned cDNAs. We constructed plasmids containing full-length cDNAs of the antigenomic (ag) L and S segments of the Armstrong (ARM) strain of the prototypic Arenavirus lymphocytic choriomeningitis virus (LCMV) flanked at their 5'- and 3'-termini by the T7 RNA polymerase (T7RP) promoter and ribozyme sequences, respectively. These plasmids directed intracellular synthesis of viral L and S ag RNA species in cells expressing plasmid-supplied T7RP. Co-expression of plasmid-supplied LCMV trans-acting factors, nucleoprotein (NP) and polymerase (L), resulted in replication and expression of L and S ag and genome RNA species, and generation of LCMV infectious progeny termed rT7/LCMV. The recombinant rT7/LCMV was unequivocally identified based on a genetic tag introduced in the recombinant S segment. In addition, rT7/LCMV exhibited growth and biological properties predicted for an ARM-like LCMV. To our knowledge, this is the first documented Arenavirus rescue, as well as of an ambisense negative strand (NS) RNA virus, entirely from cloned cDNAs. Our results extend the use of reverse genetic approaches for DNA-mediated virus rescue to all known virus families with NS RNA genome.

Entities:  

Mesh:

Year:  2006        PMID: 16476461     DOI: 10.1016/j.virol.2006.01.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  64 in total

1.  Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence.

Authors:  Brian M Sullivan; Sébastien F Emonet; Megan J Welch; Andrew M Lee; Kevin P Campbell; Juan C de la Torre; Michael B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-26       Impact factor: 11.205

2.  Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus.

Authors:  Luis Martínez-Sobrido; Elina I Zúñiga; Debralee Rosario; Adolfo García-Sastre; Juan Carlos de la Torre
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells.

Authors:  Benson Y H Cheng; Emilio Ortiz-Riaño; Juan Carlos de la Torre; Luis Martínez-Sobrido
Journal:  J Vis Exp       Date:  2013-08-01       Impact factor: 1.355

4.  CD8+ memory T cells appear exhausted within hours of acute virus infection.

Authors:  Martin P Hosking; Claudia T Flynn; Jason Botten; J Lindsay Whitton
Journal:  J Immunol       Date:  2013-09-11       Impact factor: 5.422

5.  Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.

Authors:  Sylvia Rothenberger; Christian Widmann; Stefan Kunz; Giulia Torriani; Evgeniya Trofimenko; Jennifer Mayor; Chiara Fedeli; Hector Moreno; Sébastien Michel; Mathieu Heulot; Nadja Chevalier; Gert Zimmer; Neeta Shrestha; Philippe Plattet; Olivier Engler
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

6.  Genomic and biological characterization of aggressive and docile strains of lymphocytic choriomeningitis virus rescued from a plasmid-based reverse-genetics system.

Authors:  Minjie Chen; Shuiyun Lan; Rong Ou; Graeme E Price; Hong Jiang; Juan Carlos de la Torre; Demetrius Moskophidis
Journal:  J Gen Virol       Date:  2008-06       Impact factor: 3.891

7.  Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages.

Authors:  Xavier Carnec; Sylvain Baize; Stéphanie Reynard; Laure Diancourt; Valérie Caro; Noel Tordo; Michèle Bouloy
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

8.  Sodium hydrogen exchangers contribute to arenavirus cell entry.

Authors:  Masaharu Iwasaki; Nhi Ngo; Juan C de la Torre
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

9.  Arenavirus reverse genetics for vaccine development.

Authors:  Emilio Ortiz-Riaño; Benson Yee Hin Cheng; Juan Carlos de la Torre; Luis Martínez-Sobrido
Journal:  J Gen Virol       Date:  2013-01-30       Impact factor: 3.891

Review 10.  Reverse genetics approaches to combat pathogenic arenaviruses.

Authors:  Juan C de la Torre
Journal:  Antiviral Res       Date:  2008-09-07       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.